A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumors

NCT00817518 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
145
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche